Merck sells some eye-drug assets to Japan's Santen Pharma for $600M | PharmaBoardroom
written on 13.05.2014
Tags:
,

Merck sells some eye-drug assets to Japan's Santen Pharma for $600M

TAGS: ,

The dealmaking continues in the red-hot market for eye care products with news today that Merck is offloading some of its ophthalmology products to Japan-based Santen Pharmaceutical.

Latest Report